"Psychotropic Drugs" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents).
| Descriptor ID |
D011619
|
| MeSH Number(s) |
D27.505.954.427.700
|
| Concept/Terms |
Psychotropic Drugs- Psychotropic Drugs
- Drugs, Psychotropic
- Psychopharmaceuticals
- Psychoactive Agents
- Agents, Psychoactive
- Psychoactive Drugs
- Drugs, Psychoactive
|
Below are MeSH descriptors whose meaning is more general than "Psychotropic Drugs".
Below are MeSH descriptors whose meaning is more specific than "Psychotropic Drugs".
This graph shows the total number of publications written about "Psychotropic Drugs" by people in this website by year, and whether "Psychotropic Drugs" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 4 | 4 |
| 2007 | 2 | 1 | 3 |
| 2008 | 0 | 1 | 1 |
| 2009 | 1 | 1 | 2 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 1 | 2 |
| 2012 | 2 | 1 | 3 |
| 2014 | 3 | 0 | 3 |
| 2015 | 2 | 1 | 3 |
| 2016 | 4 | 0 | 4 |
| 2017 | 7 | 0 | 7 |
| 2020 | 3 | 1 | 4 |
| 2021 | 1 | 1 | 2 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Psychotropic Drugs" by people in Profiles.
-
Bergh MS, Bogen IL, Grafinger KE, Huestis MA, ?iestad ?ML. Metabolite markers for three synthetic tryptamines N-ethyl-N-propyltryptamine, 4-hydroxy-N-ethyl-N-propyltryptamine, and 5-methoxy-N-ethyl-N-propyltryptamine. Drug Test Anal. 2024 Dec; 16(12):1544-1557.
-
Mohr ALA, Logan BK, Fogarty MF, Krotulski AJ, Papsun DM, Kacinko SL, Huestis MA, Ropero-Miller JD. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review. J Anal Toxicol. 2022 Jul 14; 46(6):e116-e185.
-
Rodrigues TB, Morais DR, Gianvecchio VAP, Aquino EM, Cunha RL, Huestis MA, Costa JL. Development and Validation of a Method for Quantification of 28 Psychotropic Drugs in Postmortem Blood Samples by Modified Micro-QuEChERS and LC-MS-MS. J Anal Toxicol. 2021 Aug 14; 45(7):644-656.
-
da Cunha KF, Oliveira KD, Cardoso MS, Arantes ACF, Coser PHP, Lima LN, Maluf ACS, Comis MAC, Huestis MA, Costa JL. Prevalence of new psychoactive substances (NPS) in Brazil based on oral fluid analysis of samples collected at electronic music festivals and parties. Drug Alcohol Depend. 2021 10 01; 227:108962.
-
Malaca S, Lo Faro AF, Tamborra A, Pichini S, Busard? FP, Huestis MA. Toxicology and Analysis of Psychoactive Tryptamines. Int J Mol Sci. 2020 Dec 04; 21(23).
-
da Cunha KF, Oliveira KD, Huestis MA, Costa JL. Screening of 104 New Psychoactive Substances (NPS) and Other Drugs of Abuse in Oral Fluid by LC-MS-MS. J Anal Toxicol. 2020 Oct 12; 44(7):697-707.
-
Matheson J, Mann RE, Sproule B, Huestis MA, Wickens CM, Stoduto G, George TP, Rehm J, Le Foll B, Brands B. Acute and residual mood and cognitive performance of young adults following smoked cannabis. Pharmacol Biochem Behav. 2020 07; 194:172937.
-
Tanielian M, Doghramji K, Certa K. Obstructive Sleep Apnea in Psychiatric Inpatients. J Nerv Ment Dis. 2020 03; 208(3):190-193.
-
Grunze A, Mago R, Grunze H. [Side effects of psychotropic medication: Suggestions for clinical practice]. Dtsch Med Wochenschr. 2017 Nov; 142(22):1690-1700.
-
Logan BK, Mohr ALA, Friscia M, Krotulski AJ, Papsun DM, Kacinko SL, Ropero-Miller JD, Huestis MA. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review. J Anal Toxicol. 2017 Sep 01; 41(7):573-610.